Form 4: Monster Beverage CSO Emelie Tirre Reports Equity Transactions
Insider Transaction Report
Monster Beverage's Chief Strategy Officer, Emelie Tirre, reported multiple equity transactions including RSU and PSU vestings, option grants, and tax-related share dispositions.
Summary
- Emelie Tirre, Chief Strategy Officer of Monster Beverage Corp, reported several transactions involving company common stock and derivative securities between March 12 and March 14, 2026.
- Transactions included the acquisition of 1,680 shares, 3,400 shares, 1,360 shares, 900 shares, and 1,750 shares of common stock through the settlement of Restricted Stock Units (RSUs).
- An additional 27,200 shares of common stock were acquired upon the vesting of Performance Share Units (PSUs) at a price of $0.
- Tirre disposed of 855 shares at $76.99, 13,840 shares at $77.11, and 3,771 shares at $77.05, all for tax withholding purposes.
- Following these transactions, Tirre's direct beneficial ownership of common stock increased to 81,763 shares.
- New grants included 11,700 Employee Stock Options with an exercise price of $77.11 and 3,900 Restricted Stock Units, both vesting in three equal installments starting March 13, 2027.
- The filing also corrected a scrivener's error from a previous Form 4 (December 16, 2025) regarding the number of vested options for a grant dated March 14, 2033.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a routine and expected filing, reflecting standard executive compensation practices and the achievement of performance criteria for PSU vesting. The increase in beneficial ownership, despite tax-related sales, is a positive for long-term alignment.
Positives
- Acquisition of 27,200 shares of common stock at $0 through PSU vesting indicates achievement of performance criteria.
- New grants of 11,700 employee stock options and 3,900 restricted stock units demonstrate continued incentive alignment with company performance.
- Overall increase in direct beneficial ownership of common stock to 81,763 shares after all reported transactions, excluding shares disposed for tax purposes.
Negatives
- Dispositions of 855 shares at $76.99, 13,840 shares at $77.11, and 3,771 shares at $77.05 were made to cover tax obligations, reducing the net shares retained from vesting events.
Future Outlook
The filing details future vesting schedules for various equity awards, indicating continued long-term incentive alignment for the Chief Strategy Officer through March 2029.
Industry Context
StockSavvy.ai notes that routine insider transactions, such as those related to equity compensation vesting and tax-related dispositions, are common across the consumer beverage industry. These transactions reflect standard executive compensation practices designed to align management interests with shareholder value over the long term.
Comparison to Industry Standards
- This Form 4 reflects standard equity compensation practices, including Restricted Stock Units (RSUs), Performance Share Units (PSUs), and Employee Stock Options, which are widely used across publicly traded companies in the consumer goods sector, such as Coca-Cola (KO), PepsiCo (PEP), and Keurig Dr Pepper (KDP).
- The vesting schedules and tax-related dispositions are typical mechanisms for executive incentive plans, aligning with global benchmarks for executive compensation structures.
Stakeholder Impact
- Shareholders: The transactions reflect standard executive compensation, aligning management incentives with shareholder interests through equity ownership. The net increase in shares held by a key executive can be seen as a positive signal of long-term commitment.
- Employees: The equity compensation plans (RSUs, PSUs, Stock Options) are part of the company's overall incentive structure, which can motivate employees, especially executives, to achieve company goals.
Next Steps
- Vesting of 11,700 Employee Stock Options in three equal installments on March 13, 2027, March 13, 2028, and March 13, 2029.
- Vesting of 3,900 Restricted Stock Units in three equal installments on March 13, 2027, March 13, 2028, and March 13, 2029.
- Remaining options for a grant with exercise price $36.62 vest on March 14, 2027.
- Remaining options for a grant with exercise price $50.82 vest in two installments: 5,000 shares on March 14, 2027, and 6,000 shares on March 14, 2028.
- Remaining options for a grant with exercise price $60.3 vest in three installments: 3,600 shares on March 14, 2027; 4,500 shares on March 14, 2028; and 5,400 shares on March 14, 2029.
- Remaining options for a grant with exercise price $55.09 vest in three equal installments on March 14, 2027, March 14, 2028, and March 14, 2029.
- Remaining restricted stock units for a grant vest on March 14, 2027.
- Remaining restricted stock units for another grant vest in two installments: 1,700 units on March 14, 2027, and 2,040 units on March 14, 2028.
- Remaining restricted stock units for another grant vest in three installments: 1,200 units on March 14, 2027; 1,500 units on March 14, 2028; and 1,800 units on March 14, 2029.
- Remaining restricted stock units for another grant vest in three equal installments on March 14, 2027, March 14, 2028, and March 14, 2029.
Key Dates
| Date | Description |
|---|---|
| 12/16/2025 | Date of previous Form 4 filing which contained a scrivener's error. |
| 03/12/2026 | Transaction date for RSU settlement and tax-related share disposition. |
| 03/13/2026 | Transaction date for PSU vesting, tax-related share disposition, and grant of new stock options and restricted stock units. |
| 03/14/2026 | Transaction date for multiple RSU settlements and tax-related share disposition. |
| 03/16/2026 | Signature date of the reporting person's attorney-in-fact. |
| 03/13/2027 | First vesting date for newly granted options and restricted stock units. |
| 03/14/2027 | First vesting date for several outstanding options and restricted stock units. |
| 03/13/2028 | Second vesting date for newly granted options and restricted stock units. |
| 03/14/2028 | Second vesting date for several outstanding options and restricted stock units. |
| 03/13/2029 | Third vesting date for newly granted options and restricted stock units. |
| 03/14/2029 | Third vesting date for several outstanding options and restricted stock units. |
| 03/12/2031 | Expiration date for Employee Stock Option with exercise price $44.47. |
| 03/14/2032 | Expiration date for Employee Stock Option with exercise price $36.62. |
| 03/14/2033 | Expiration date for Employee Stock Option with exercise price $50.82. |
| 03/14/2034 | Expiration date for Employee Stock Option with exercise price $60.3. |
| 03/14/2035 | Expiration date for Employee Stock Option with exercise price $55.09. |
| 03/13/2036 | Expiration date for Employee Stock Option with exercise price $77.11. |
Recommendation
holdThis Form 4 filing details routine equity compensation transactions for a key executive, including vesting of awards and tax-related sales, along with new grants. These are standard events and do not provide new information that would significantly alter the fundamental investment thesis for Monster Beverage. The transactions reflect ongoing alignment of management incentives with shareholder value but do not suggest a strong buy or sell signal based solely on this filing.
Keywords
Monster Beverage, MNST, Emelie Tirre, Chief Strategy Officer, SEC Form 4, Insider Trading, Stock Options, Restricted Stock Units, Performance Share Units, Equity Compensation, Share Ownership, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.